BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17717663)

  • 21. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
    Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes for use in cancer immunotherapy.
    Ozaki Y; Kontani K; Teramoto K; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Asai T; Ohkubo I
    Biochem Biophys Res Commun; 2004 May; 317(4):1089-95. PubMed ID: 15094380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity without immunoselection: a mutant but functional antioxidant enzyme retained in a human metastatic melanoma and targeted by CD8(+) T cells with a memory phenotype.
    Sensi M; Nicolini G; Zanon M; Colombo C; Molla A; Bersani I; Lupetti R; Parmiani G; Anichini A
    Cancer Res; 2005 Jan; 65(2):632-40. PubMed ID: 15695408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma.
    Nishizaka S; Gomi S; Harada K; Oizumi K; Itoh K; Shichijo S
    Cancer Res; 2000 Sep; 60(17):4830-7. PubMed ID: 10987294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601.
    Satoh M; Takamiya Y; Oka S; Tokunaga K; Takiguchi M
    Vaccine; 2005 May; 23(29):3783-90. PubMed ID: 15893615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gene expression profiles in a human T-cell line stimulated with a tumor-associated self-peptide versus an enhancer agonist peptide.
    Palena C; Schlom J; Tsang KY
    Clin Cancer Res; 2003 May; 9(5):1616-27. PubMed ID: 12738714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.
    Vikman S; Essand M; Cunningham JL; de la Torre M; Oberg K; Tötterman TH; Giandomenico V
    Acta Oncol; 2005; 44(1):32-40. PubMed ID: 15848904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.
    Atagunduz P; Appel H; Kuon W; Wu P; Thiel A; Kloetzel PM; Sieper J
    Arthritis Rheum; 2005 Mar; 52(3):892-901. PubMed ID: 15751060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis.
    Kita H; Matsumura S; He XS; Ansari AA; Lian ZX; Van de Water J; Coppel RL; Kaplan MM; Gershwin ME
    Hepatology; 2002 Oct; 36(4 Pt 1):918-26. PubMed ID: 12297839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of an HLA-DR-binding peptide derived from Wilms' tumour 1 protein and demonstration of in vitro immunogenicity of WT1(124-138)-pulsed dendritic cells generated according to an optimised protocol.
    Knights AJ; Zaniou A; Rees RC; Pawelec G; Müller L
    Cancer Immunol Immunother; 2002 Jul; 51(5):271-81. PubMed ID: 12070714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients.
    Kiessling A; Schmitz M; Stevanovic S; Weigle B; Hölig K; Füssel M; Füssel S; Meye A; Wirth MP; Rieber EP
    Int J Cancer; 2002 Dec; 102(4):390-7. PubMed ID: 12402309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
    Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
    J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1.
    Ayyoub M; Zippelius A; Pittet MJ; Rimoldi D; Valmori D; Cerottini JC; Romero P; Lejeune F; Liénard D; Speiser DE
    Clin Cancer Res; 2003 Feb; 9(2):669-77. PubMed ID: 12576434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8+ T cells reactive to survivin antigen in patients with multiple myeloma.
    Grube M; Moritz S; Obermann EC; Rezvani K; Mackensen A; Andreesen R; Holler E
    Clin Cancer Res; 2007 Feb; 13(3):1053-60. PubMed ID: 17289902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The characteristics of anti-B-cell malignance cytotoxic T lymphocytic clones induced by lymphoma relative peptides].
    Guo XL; Zhu P; Zhu X; Liu J; Ou Y; Du JW
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1476-80. PubMed ID: 16061026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.
    So T; Hanagiri T; Chapiro J; Colau D; Brasseur F; Yasumoto K; Boon T; Coulie PG
    Cancer Immunol Immunother; 2007 Feb; 56(2):259-69. PubMed ID: 16758204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.
    Slager EH; van der Minne CE; Goudsmit J; van Oers JM; Kostense S; Havenga MJ; Osanto S; Griffioen M
    Cancer Gene Ther; 2004 Mar; 11(3):227-36. PubMed ID: 14726960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
    Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
    Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
    Weichold FF; Mueller S; Kortsik C; Hitzler WE; Wulf MJ; Hone DM; Sadoff JC; Maeurer MJ
    Genes Immun; 2007 Jun; 8(4):334-43. PubMed ID: 17429413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.